The significance of GCK in sensing ambient glucose has led to the hypothesis that pharmaceutical manipulation of this physiological mechanism in the form of glucokinase activators could present an effective method of treating hyperglycaemia as a result of type 2 diabetes [63]. The gene discussed is GCK; the disease is type 2 diabetes mellitus.